We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Contribution of Pain and Inflammation in IBS

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01436760
First Posted: September 20, 2011
Last Update Posted: March 26, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Florida
September 16, 2011
September 20, 2011
March 26, 2012
May 2011
March 2012   (Final data collection date for primary outcome measure)
Polymorphisms [ Time Frame: one year ]
The goal of the study isd to identify possible polymorphisms on the loci of canidate genes that may be involved in modulation of pain and inflammation in irritable Bowel Syndrome.
Same as current
Complete list of historical versions of study NCT01436760 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Genetic Contribution of Pain and Inflammation in IBS
Genetic Contribution of Pain and Inflammation in Irritable Bowel Syndrome.
The goal of the study is to identify possible polymorphisms on the loci of candidate genes that may be involved in modulation of pain and inflammation in irritable bowel syndrome.
Stored and de-linked blood or DNA from subjects with IBS will be utilized for analysis for possible polymorphisms at predetermined genetic loci located in chosen genes.
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Retention:   Samples With DNA
Description:
The delinked blood/DNA is stored in the genetics laboratory and they will be analyzed for possible polymorphisms
Probability Sample
Generic laboratory blood bank
Irritable Bowel Syndrome
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
72
March 2012
March 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects with IBS and previously stored samples

Exclusion Criteria:

  • Subjects without IBS and no previously stored samples
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01436760
132-2011
No
Not Provided
Not Provided
University of Florida
University of Florida
Not Provided
Principal Investigator: Baharak Moshiree, MD, MS University of Florida
University of Florida
March 2012